Long-term impact of COVID-19 on haemophilia: a multicenter study in Southwest China.

Publication date: Jul 29, 2026

The coronavirus disease 2019 (COVID-19) pandemic is not yet over as millions of people are still diagnosed with persistent symptoms of COVID-19 (long COVID) worldwide. Despite some advances in haemophilia research, the precise relationship between COVID-19 and haemophilia remains elusive, warranting further investigation. A total of 254 cases of people with haemophilia (PwH) infected with COVID-19 from Southwest China were enrolled in the present study. Baseline characteristics, clinical manifestations, treatment methods, and vaccination data were collected and analyzed. Patients were followed up for clinical characteristics at 1, 2, 4, and 16 weeks and 6 months after COVID-19. The spontaneous bleeding characteristics, joint functional status (assessed by the Haemophilia Joint Health Score [HJHS] and Haemophilic Early Arthropathy Detection with Ultrasound [HEAD-US]), coagulation factor inhibitors formation, characteristics of long COVID and changes in mental state were analyzed. The clinical features of the 254 PwH were analyzed in the study. A significant reduction in spontaneous bleeding frequency was observed in all body regions except the gingiva during COVID-19 (p  0. 05. In addition, one patient developed coagulation factor Ⅷ inhibitors after COVID-19 infection. This study indicates that spontaneous bleeding episodes are decreased among PwH during COVID-19 infection, and the infection does not cause deterioration of joint function. In addition, it underscores the necessity of close monitoring of long COVID-related impacts as well as COVID-19-associated mental health conditions in PwH. Not applicable.

Open Access PDF

Concepts Keywords
China Adult
Coronavirus Aged
Haemophilia China
Precise Coagulation factor inhibitors
Vaccination COVID-19
COVID-19
Female
Haemophilia
Hemophilia A
Hemorrhage
Humans
Long COVID
Male
Mental health
Middle Aged
Post-Acute COVID-19 Syndrome
SARS-CoV-2
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease MESH haemophilia
disease MESH long COVID
disease MESH bleeding
disease MESH Arthropathy
disease MESH infection
disease MESH Infectious Diseases
pathway REACTOME Reproduction
disease MESH included
disease MESH hypercoagulability
disease MESH inflammation
disease MESH cytokine storm
disease MESH fatigue
disease MESH cough
disease MESH cognitive impairment
drug DRUGBANK Coenzyme M
drug DRUGBANK Tretamine
disease MESH Anxiety
disease MESH DASS
drug DRUGBANK Trestolone
drug DRUGBANK Esomeprazole
disease MESH syndrome
drug DRUGBANK Ademetionine

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *